Ertugliflozin + Sitagliptin
Composition
This formulation contain combination of Ertugliflozin and Sitagliptin l as active agent
Indications
the treatment of type 2 diabetes mellitus in adults
Side effects
urinary tract infections, upper respiratory tract infections, nasopharyngitis, headache, and hypoglycemia
Precautions
aution is advised in patients with a history of genital mycotic infections or urinary tract infections and pancreatitis
Contraindications
Contraindications include severe renal impairment, end-stage renal disease
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet